BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for MEI Pharma, Inc. (MEIP)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for MEI Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-11
5:29 pm
Sale
2020-12-3113GMEI Pharma, Inc.
MEIP
BIOTECHNOLOGY VALUE FUND L P279,466
4.900%
-64,856decrease
(-18.84%)
Filing